Lisinopril Renal Dosing
For patients with impaired renal function, lisinopril requires dose reduction based on creatinine clearance: no adjustment needed if CrCl >30 mL/min; reduce initial dose to 50% (2.5-5 mg daily) if CrCl 10-30 mL/min; and start at 2.5 mg daily for hemodialysis patients or CrCl <10 mL/min, with maximum titration to 40 mg daily as tolerated. 1
Dosing by Creatinine Clearance
Normal to Mild Renal Impairment (CrCl >30 mL/min)
- No dose adjustment required 1
- Standard starting doses apply:
Moderate Renal Impairment (CrCl 10-30 mL/min)
- Reduce initial dose to 50% of standard dose 1
- Titrate upward as tolerated to maximum 40 mg daily 1
- Accumulation is highly correlated with creatinine clearance in this range 2
- Effective half-life doubles compared to normal renal function 2
Severe Renal Impairment (CrCl <10 mL/min or Hemodialysis)
- Start at 2.5 mg once daily regardless of indication 1
- Titrate cautiously to maximum 40 mg daily as tolerated 1
- Significant drug accumulation occurs at this level of renal impairment 3, 4
- Effective half-life triples compared to normal renal function 2
- Peak concentrations are higher and time to peak is extended 2
Monitoring Requirements
Initial Monitoring
- Check renal function and serum potassium within 1-2 weeks of initiation or dose increase 5
- Baseline assessment before starting therapy is essential 5
Ongoing Monitoring
- Renal function tests every 3 months during chronic therapy if on ACE inhibitors 5
- More frequent monitoring (days to 2 weeks) when making dose adjustments 5
- Minimum 6-monthly monitoring for stable patients 5
Critical Thresholds
- Discontinue if potassium ≥6 mmol/L 5
- Reduce dose if serum creatinine increases >30% or eGFR decreases >25% from baseline 5
- If lesser degree of renal deterioration occurs, recheck in 1-2 weeks but do not reduce dose unless above thresholds are exceeded 5
Clinical Pharmacology Considerations
Drug Accumulation
- Lisinopril accumulation is highly correlated with creatinine clearance 2
- Steady state is achieved in 2-3 days with normal renal function, but accumulation occurs with CrCl ≤30 mL/min 3
- Despite accumulation in severe renal failure, excessive antihypertensive effects do not necessarily occur 4
Efficacy in Renal Impairment
- Blood pressure reduction occurs across all levels of renal function over 24 hours 2, 4
- ACE activity is suppressed to <10% of baseline from 4-24 hours after dosing in all renal function groups 4
- Proteinuria may decrease with appropriate dosing (e.g., from 3.9 to 2.7 g per 24 hours) 6
- Overall GFR typically remains stable during treatment when appropriately dosed 7
Important Caveats
Hyperkalemia Risk
- Risk increases with concomitant use of higher ACE inhibitor doses (lisinopril ≥10 mg daily) 5
- Avoid potassium supplements or reduce them when initiating lisinopril 5
- Avoid NSAIDs and COX-2 inhibitors which increase hyperkalemia risk 5
- Risk is particularly elevated in patients with diabetes requiring insulin 5
Hypotension Management
- If systolic BP drops to ≤100 mmHg, reduce to 5 mg daily maintenance dose 1
- If prolonged hypotension occurs (systolic BP <90 mmHg for >1 hour), withdraw lisinopril 1
- Initial hypotension does not preclude careful subsequent titration after effective hypotension management 1